Background. Given high dialysis mortality rates for patients older than 60 years, accepting a kidney with a high Kidney Donor Profile Index (KDPI) score could enable earlier and potentially preemptive transplantation (preKT). However, evidence regarding the risks of high KDPI allografts in older patients is limited. Our objective was to determine the relative benefit for older patients of KDPI greater than 85% transplant either preemptively or not compared with remaining on the waitlist. Methods. United Network of Organ Sharing data from 2003 to 2012 for adult deceased donor kidney transplant candidates was analyzed to evaluate patient survival in patients older than 60 years for preKT and non-preKT KDPI greater than 85% transplants compared with candidates remaining on the waitlist including patients who received KDPI 0% to 85% transplants according to multivariate Cox regression models. Results. In the first year posttransplant for KDPI greater than 85% of transplants in recipients older than 60 years, preKT had a reduced mortality hazard (hazards ratio [HR], 0.61; 95% confidence interval [95% CI], 0.41-0.90) and non-preKT an increased mortality hazard (HR, 1.15; 95% CI, 1.03-1.27) compared with the waitlist including KDPI 0% to 85% transplant recipients. At 1 to 2 years and after 2 years, both KDPI greater than 85% groups had significant reductions in mortality (1-2 years: preKT HR, 0.38; 95% CI, [0.23-0.60] and non-preKT HR, 0.52; 95% CI, 0. and 2+ years: preKT HR, 0.50; 95% CI, 0.64; 95% CI, respectively). Conclusions. PreKT and non-preKT KDPI greater than 85% transplant was associated with lower mortality hazard after the first year compared with the waitlist including KDPI 0% to 85% transplants in patients older than 60 years. Further consideration should be given to increased utilization of high KDPI grafts in older patients with the goal of avoiding or limiting time on dialysis.
D
espite improvements in dialysis-related mortality over the past few decades, only 54% of dialysis patients survive past 3 years. 1 Kidney transplantation results in improved long-term survival in older patients compared with dialysis. 2, 3 Yet tragically, almost half of patients older than 60 years are projected to die before receiving a kidney transplant due to organ shortages and prolonged wait times nationally. 4 Transplantation without prior dialysis, termed preemptive kidney transplantation (preKT), has been linked to improved patient and graft survival and decreased costs. [5] [6] [7] In addition, by avoiding the costs of dialysis, which are highest at initiation, preKT has the potential to translate into vast cost savings in the care of patients with end-stage renal disease (ESRD). 8, 9 Despite evidence demonstrating superior patient and graft survival after preKT, only a small minority of transplants are performed without a period of pretransplant dialysis. Currently, only 11% of deceased donor kidney transplants (DDKTs) are performed preemptively, and only 2.5% of all patients with ESRD undergo preKT. 5, 10, 11 Nonideal renal allografts, previously designated as extended criteria donor (ECD) kidneys, represent 1 opportunity for increasing access to earlier and potentially preemptive transplantation in older patients.
With the implementation of the Kidney Donor Profile Index (KDPI) score, there is now increased precision in the measurement of predicted renal allograft survival using a range of 0% to 100%, with 100% representing the highest risk of graft failure. 12 In December 2014, the KDPI score became the standard measure used for deceased donor kidney allocation, with KDPI greater than 85% replacing ECD as the designation of higher-risk grafts. Kidney Donor Profile Index greater than 85% kidneys are offered to an abbreviated list of patients who have consented to accept a nonideal graft, thereby potentially offering a shorter wait time when compared with waiting for a lower KDPI graft. However, currently, more than 60% of these grafts are discarded representing about 3000 kidneys annually. 13 Despite some conflicting reports, overall prior research demonstrated a survival benefit with ECD transplantation compared with remaining on the waiting list in older patients.
14-17 A more recent analysis showed improved longterm patient survival benefits with higher KDPI kidneys (KDPI > 70%) in patients older than 50 years or at centers with median wait times longer than 33 months. 15 To date, there has been no examination of the long-term survival benefit according to the KDPI greater than 85% threshold that is now used for allocation or if survival advantages remain when evaluating patients older than 60 years separately. More importantly, prior research has not explored the interplay between benefits associated with preKT and risks associated with high KDPI allografts.
Our objective was to determine the relative benefit of both preemptive and nonpreemptive deceased donor kidney transplantation using kidneys with a KDPI greater than 85% in older recipients. We propose that increased utilization of KDPI greater than 85% kidneys in older ESRD patients will result in improved patient survival by avoiding or limiting time on dialysis. These questions are timely ones given the current climate of increased concern surrounding Scientific Registry for Transplant Recipients (SRTR) program specific reports. Much concern regarding increased risks of transplant center flagging has focused on the risks associated with transplanting older patients or using higher risk grafts.
MATERIALS AND METHODS
We performed a retrospective comparative analysis of adult kidney candidates (n = 369103) and DDKT recipients (n = 95 814) from June 1, 2003, through September 31, 2012, based on United Network of Organ Sharing registry data. Patients listed for multiorgan transplants (including kidney-pancreas transplantation) and recipients of living donor kidney transplants (LDKT) were excluded. Primary and retransplant patients were included. Patients were followed up until death or administrative censorship (end of study October 1, 2013) . Patients who were removed from the waitlist remained in the risk set until death or until the end of the study period according to intention to treat principles. Recipients of DDKT with missing data necessary for the calculation of KDPI (n = 56/95 814) were excluded.
We compared patient survival among patients older than 60 years according to the groups defined as follows. We compared survival for KDPI greater than 85% recipients (both preKT and non-preKT) to the "conservative approach" of remaining on the waitlist, including those who subsequently received a KDPI 0% to 85% DDKT. To justify the risks of KDPI greater than 85% transplants, patient survival would need to be superior to survival of patients who refused a KDPI greater than 85% kidney and remained on the list with the chance of later receiving a KDPI 0% to 85% kidney. Consequently, we compared survival for KDPI greater than 85% transplant as a time-varying exposure such that patients entered the high KDPI risk set once they received a KDPI greater than 85% transplant compared with patients on the waitlist who either remained on waitlist, received a KDPI 0% to 85% transplant, or died according to methodology as previously published. 15 Patients entered the waitlist group at time of listing. For the waitlist including KDPI 0% to 85% transplants, patients were followed up from time from listing to death (on waitlist or after DDKT with KDPI 0-85%) or administrative censorship. To address concerns related to immortal time bias, survival was analyzed for patients who underwent KDPI greater than 85% transplant at the time they entered the risk set (underwent KDPI >85% transplant). As such, no pretransplant time was included in the survival time calculated for the KDPI greater than 85% transplant group.
Comparison groups were defined according to the cutoff of KDPI greater than 85% used for allocation under the Kidney Allocation System. Additionally, we compared posttransplant patient survival, overall graft survival, and death-censored graft survival for preKT KDPI greater than 85%, non-preKT KDPI greater than 85%, preKT KDPI 0% to 85%, and non-preKT KDPI 0% to 85% recipients. We also compared survival differences according to the same groups for patients older than 50 years. We focused our analysis on older patients because the majority of transplants with ECD or high KDPI kidneys were in older recipients.
Recipient characteristics compared among the groups included age, sex, race, primary payer, presence of diabetes, body mass index (BMI), and sensitization according to calculated panel-reactive antibody (cPRA). Calculated panelreactive antibody was only uniformly reported to United Network of Organ Sharing since 2007 so this data point is missing on more than 40% of patients in the cohort (2003) (2004) (2005) (2006) (2007) . As such, missing cPRA was included as a variable in multivariate analyses to avoid censoring of these patients. A complete case analysis excluding patients without a cPRA and an analysis of only the later cohort (2007) (2008) (2009) (2010) (2011) (2012) were included as sensitivity analyses. Kruskal-Wallis and χ 2 tests were used to compare continuous and categorical variables, respectively, among the groups. Patient and overall and death-censored graft survival were compared using Kaplan-Meier curves and log-rank tests. For the waitlist including KDPI 0% to 85% transplant group, time from listing to death (on waitlist or after DDKT with KDPI 0-85%) or administrative censorship was analyzed. Factors included in survival models were chosen a priori based on clinical significance and according to significant differences (P < 0.05) in recipient characteristics between treatment and control groups including recipient age, race, sex, blood type, preemptive status, diabetes, BMI, and cPRA. Additionally, recipient primary insurance, height, weight, diagnosis, year of transplant, and region were examined, but not included in final models according to goodness of fit tests as described below. Only pretransplant characteristics were included in survival models as to help inform decision making at time of acceptance of organ offer. Additional donor variables beyond KDPI were not included to avoid confounding, because the most relevant donor variables at time of organ offer are included in the KDPI. Hazards ratios (HR) with 95% confidence intervals (CI) are reported. Schoenfeld residuals were examined for models globally and for individual covariates to assess for potential departures from the proportional hazards assumption. Additionally, a graphical assessment of proportional hazards was performed according to log-log survival curves. Given evidence of a time-varying effect in the non-preKT KDPI greater than 85% transplant group compared with the reference, we constructed separate models for the posttransplant hazards in the first year, second year, and thereafter for preKT and non-preKT KDPI greater than 85% transplants to provide more detailed assessment of hazard according to time. Goodness of fit was assessed according to χ 2 statistics for the likelihood ratio tests for nested models. A 2-sided P value less than 0.05 was considered significant. All analyses were performed with STATA software (version 11.2, College Station, TX).
RESULTS

Study Population
Of 363 103 adult kidney transplant candidates, 11% (10 106/94 881) received a preemptive DDKT. In recipients older than 60 years, the rate of preKT using deceased donor kidneys was 13% (2842/21 700). Of preKT with deceased donor kidneys in recipients older than 60 years, 19% (536/2842) were with kidney allografts with a KDPI greater than 85%. Preemptive transplantation KDPI greater than 85% recipients older than 60 years were more often female, more often white, and less likely to have diabetes. There were differences according to blood type with more preKT in AB recipients and fewer preKT for O and B blood types (Table 1) . Patients with Medicare as primary payer had a lower rate of preemptive transplant (Medicare was the primary payer for 76% of the waitlist including KDPI 0-85% group and specifically for 62% of preKT KDPI 0-85%, 67% of preKT KDPI >85%, 75% non-preKT KDPI 0-85%, and 77% of non-preKT KDPI >85% transplants respectively, P < 0.01). The time from listing to transplant was shorter for KDPI greater than 85% recipients in patients older than 60 years (KDPI >85% 779 ± 9 days vs KDPI 0-85% 808 ± 4 days, P = 0.01).
Survival
Because our major goal was to assess the outcomes with different options, we first compared receiving a kidney transplant with KDPI greater than 85% kidney to the other option of remaining on the waiting list and potentially receiving a kidney transplant with a KDPI 0% to 85% kidney (termed waitlist including KDPI 0-85%). This latter group included patients who either: (1) died waiting, (2) remained on the list alive but were not transplanted, or (3) received a kidney transplant (preemptive or nonpreemptive) with a KDPI 0% to 85% graft. For candidates older than 60 years, both preKT and non-preKT with KDPI greater than 85% grafts had increased patient survival compared with waitlist including KDPI 0% to 85% transplants, log rank P < 0.01 (Figure 1) . One-and 3-year patient survival rates were 95% and 85% for preKT with KDPI greater than 85%, 90%, and 77% for non-preKT with KDPI greater than 85%, and 92% and 72% for waitlist including KDPI 0% to 85% transplant.
To avoid confounding due to differences in recipient characteristics between groups, we compared patient survival adjusting for initial age at listing, gender, race, diabetes, BMI, ABO blood type, and cPRA. Both preemptive and nonpreemptive KDPI greater than 85% recipients have reduced mortality hazards after the first year compared with the waitlist including KDPI 0% to 85% transplants (Table 2 ). In the first year posttransplant for KDPI greater than 85% recipients, preKT had a reduced mortality hazard (HR, 0.61; 95% CI, 0.41-0.90) and non-preKT an increased mortality hazard (HR, 1.15; 95% CI, 1.03-1.27) compared with the waitlist including KDPI 0% to 85% transplant recipients. At 1 to 2 years and after 2 years, both KDPI greater than 85% groups had significant reductions in mortality (1-2 years: preKT HR, 0.38; 95% CI, 0.23-0.60 and nonpreKT HR, 0.52; 95% CI, 0.45-0.61; 2+ years: preKT HR, 0.50; 95% CI, 0.38-0.66 and non-preKT HR, 0.64; 95% CI, 0.58-0.70, respectively). Of the covariates included in our models, diabetes had the highest increase in mortality hazards for all periods evaluated (0-1 years: HR, 1.33; 95% CI, 1.26-1.41; 1-2 years: HR, 1.62; 95% CI, 1.53-1.71; 2+ years: HR, 1.49; 95% CI, 1.44-1.55).
Sensitivity analyses based on a complete case and an analysis of the 2007 to 2012 cohort were performed to address concerns related to missing cPRA in earlier cohort. These analyses resulted in stable findings of a significant reduction in mortality hazards in the KDPI greater than 85% transplant groups as described above.
Posttransplant Patient and Graft Survival
Posttransplant patient survival was highest for preKT with KDPI 0% to 85%, and patients on the waitlist who were not transplanted had the lowest survival. Patient survival was improved with preKT for KDPI greater than 85% recipients compared with non-preKT for KDPI 0% to 85% recipients (log rank for 2 group comparison, P = 0.01) (Figure 2A) . One-and 3-year patient survival rates were 96% and 90% for preKT in KDPI 0% to 85% recipients, 95% and 88% for preKT in KDPI greater than 85% recipients, 92% and 82% for non-preKT with KDPI 0% to 85% recipients, 91% and 79% for non-preKT in KDPI greater than 85% recipients, and 90% and 64% for waitlisted patients who were not transplanted during the study period (P < 0.01).
PreKT with KDPI 0% to 85% was associated with improved overall and death-censored graft survival, and non-preKT with KDPI greater than 85% has statistically worse graft survival ( Figures 2B and C) . Overall and death-censored graft survival was not significantly different between preKT with KDPI greater than 85% and non-preKT with KDPI 0% to 85% (log rank; P = 0.14 and 0.09, respectively). One-year overall graft survival was 93% for preKT with KDPI 0% to 85%, 90% for preKT with KDPI greater than 85%, 88% for non-preKT with KDPI 0-85%, and 84% for non-preKT with KDPI greater than 85%, respectively.
Causes of Graft Failure
Given concerns about higher rates of graft thrombosis after preKT, causes of graft failure among the transplant groups were compared. The proportion of graft thrombosis as the cause of failure was higher after preKT (12% in preKT KDPI 0-85%, 6% in non-preKT KDPI >85%, 7.5% in preKT KDPI >85%, and 6% in non-preKT KDPI >85%). However, the incidence of graft thrombosis was overall quite low with a rate of 1% in preKT KDPI 0% to 85%, 0.6% in non-preKT KDPI 0-85%, 0.9% in preKT KDPI >85%, and 1.1% non-preKT KDPI >85%.
Recipients Older Than 50 years
In recipients older than 50 years, the rate of preKT was 12% (5561/47 361), and 16% (885/5561) of these were from KDPI greater than 85% deceased donors. Similar outcomes were seen when considering all patients older than 50 years, suggesting that receiving a kidney transplant with a KDPI greater than 85% was associated with increased patient survival as well (Figure 3) . Additionally, overall graft survival was similar with 1-year survival of 94% for preKT Posttransplant hazard ratios comparing preemptive and non-preemptive KDPI >85% to the conservative approach of remaining on the waitlist including possible receipt of a KDPI 0-85% transplant with KDPI 0% to 85%, 90% for non-preKT with KDPI 0% to 85%, 90% for preKT with KDPI greater than 85%, and 85% for non-preKT with KDPI greater than 85% (P < 0.01).
DISCUSSION
Decisions regarding kidney transplantation in older recipients are complex, and an evidence-based approach is lacking. One of the most important concerns is whether avoiding or limiting time on dialysis by accepting high KDPI kidney offers a true survival benefit over waiting longer for a lower KDPI kidney. Based on this current retrospective study of national registry data, recipients of KDPI greater than 85% kidneys who were older than 60 years had lower mortality risks after 1 year posttransplant than those patients who remained on the waitlist and potentially received a lower KDPI kidney. Non-preKT did have an increased mortality hazard in the first year compared with the conservative approach of remaining on the waiting list including possible receipt of a KDPI 0% to 85% transplant. Our analysis is the first to evaluate the benefit of transplant according to the KDPI greater than 85% threshold used for allocation and to focus more specifically on patients over 60 years old. Additionally, prior research had failed to explore the interplay between benefits from preKT and risks associated with high KDPI and ECD kidneys.
Living donor kidney transplant represents the ideal option for most patients when a suitable living donor is available. However, an available living donor is not a reality for all kidney candidates. As such, we limited our analysis to those patients who were not able to identify a suitable living donor and undergo LDKT. Deceased donor kidney transplant using high KDPI kidneys represent another potential opportunity for increasing the accessibility of preKT for more patients. The Eurotransplant Senior Program prioritizing earlier allocation of older than 65 years kidneys to local older than 65 years recipients was successful in reducing median wait times, increasing utilization of older donor kidneys and preserving comparable survival rates. 18, 19 However, concerns about the graft quality and associated survival have thus far limited the increasing use of these organs in the United States resulting in discard rates. Under the Kidney Allocation Scheme, more than 60% of KDPI greater than 85% graft continue to be discarded. 13 Since 2007, Centers for Medicaid and Medicare Services (CMS) has used first year patient and graft survival metrics published by the SRTR as a mainstay of maintaining CMS certification. These metrics and the SRTR program specific reports are also widely used by private payers for determining centers of excellence and contracting. Given this current climate of increased oversight and regulation of transplant centers based on patient and graft survival metrics, some transplant programs have adopted more conservative acceptance patterns regarding both higher risk donor organs and higher risk candidates such as older patients. [20] [21] [22] [23] [24] This potentially limits access to transplant for older patients especially with respect to the utilization of high KDPI grafts despite the evidence presented herein regarding survival benefit compared with dialysis. Centers flagged according to CMS conditions of participation decreased their overall transplant rates and to an even greater degree acceptance of ECD kidneys during a period of overall transplant growth at remaining centers. 20, 21 Although these survival metrics are risk-adjusted by the SRTR according to recipient age and donor KDPI, concerns regarding the adequacy of this risk adjustment have been ongoing and pervasive. As such, proposals to exclude KDPI greater than 85% transplants from transplant center regulatory metrics or to measure these graft outcomes separately have been suggested to encourage utilization of the organs nationally.
Risks of graft thrombosis represent a potential additional source of concern when considering increasing rates of preKT. Increased risks of graft thrombosis after preKT have been previously identified. 25, 26 Our analysis confirmed a higher proportion of graft failures in the preKT were related to graft thrombosis. However, the overall incidence of graft thrombosis was very low (<1% in the preKT groups), suggesting that the benefits of preKT likely outweigh this risk.
In this analysis, patients who were inactivated on the list after being listed active were included according to intention to treat principles because this analysis was intended to reflect the potential benefit of earlier transplant through the acceptance of high KDPI grafts. A common concern involved in caring for and transplanting older patients relates to the potential for "aging off the list" because many patients experience progression of disease and become unsuitable for transplant before they can become transplanted due to long wait times. Still to confirm the stability of our findings of a benefit of KDPI greater than 85% transplant, we performed a sensitivity analysis excluding all patients whose final status on the list was inactive. Both preKT and nonpreKT KDPI greater than 85% still had a significant decrease in hazards according to multivariate models.
Although the registry is a reliable and robust source for tracking both patient and graft survival, this analysis, like all analyses of national registry data, is limited by a lack of granularity regarding many patient and socioeconomic characteristics that may influence earlier referral and transplant and health outcomes. This concern is highlighted as the preKT group has lower rates of diabetes and Medicare as the primary payer which have been associated with improved healthcare outcomes including survival in numerous studies. To address these concerns, we compared survival according to multivariate regression models adjusting for differences in recipient characteristics. Additionally, we did a sensitivity analysis excluding retransplant patients given typical worse survival in those patients confirming significant reductions in mortality hazards for the KDPI greater than >85% transplant groups. Additionally, to address concerns related to immortal time bias, survival was analyzed for patients who underwent KDPI greater than 85% transplant at the time they entered the risk set by undergoing high KDPI transplant. These survival benefits are despite only a mean reduction in wait time of 29 days between recipients of KDPI greater than 85% and KDPI 0% to 85% grafts in patients older than 60 years. Given the allocation structure of the new Kidney Allocation Scheme, a greater difference in wait times might be expected. However, we believe that this statistically significant but relatively small difference reflects the heterogeneity of listing and transplant practices according to centers.
14 Potentially, more uniform practices across centers could result in larger reductions in mean wait times between groups potentially magnifying survival benefits derived from decreased wait times.
Although registry data cannot definitively address all potential selection bias, our findings suggest that one can advise older patients that accepting a high KDPI kidney is at least as safe as initiating or remaining on dialysis and waiting for a lower KDPI kidney. Similarly, given improved patient and graft survival at 1 year with preKT for KDPI greater than 85% grafts compared with non-preKT for KDPI 0-85%, consideration should be given to achieving preKT whenever possible as this option was associated with improved outcomes for both the patient and for transplant center regulatory metrics which further benefit from the increased risk adjustment associated with high KDPI grafts. Despite the limitations of lack of randomization and differing characteristics among the comparison groups, we believe that the findings included herein provide helpful insights regarding the difficult decisions involved in caring for these patients especially given the inability to address these questions with randomized controlled trials.
CONCLUSIONS
Kidney Donor Profile Index greater than 85% transplantation is an acceptable option for older patients compared with the remaining on the waiting list and potentially receiving a KDPI 0% to 85% kidney. Kidney Donor Profile Index greater than 85% transplantation especially preKT was associated with increased long-term survival compared with the conservative approach of remaining on the waitlist and potentially receiving a KDPI 0% to 85% transplant in patients older than 60 years and in those older than 50 years. NonpreKT with KDPI greater than 85% did have an increased mortality hazard in the first year compared with the conservative approach, but mortality hazards were reduced after the first year. Death-censored graft survival was lower overall for KDPI greater than 85% transplants, but differences in graft survival were minimal when comparing preKT with KDPI greater than 85% with non-preKT 0% to 85% which might be the more expected result of refusing a KDPI greater than 85% kidney. Using KDPI greater than 85% kidneys in older patients should be considered with the goal of avoiding or limiting time on dialysis.
